From diagnosis to national spotlight: Carver High alum inspires change in prostate cancer awareness

After sharing his story of a missed diagnosis and family silence, Gregory Jacob Jr.'s advocacy journey takes him from the ...
The Lancet

CYCLONE 2: no impact on prostate cancer forecast

Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...
The LancetOpinion

Subcutaneous immunotherapy—a wolf in sheep's clothing?

Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
TipRanks on MSN

Bayer’s Innovative Approach in Prostate Cancer Treatment: A Phase 1 Study Update

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG is conducting a Phase 1 clinical study titled A Phase 1 ...

Scientists Uncover New Weak Spot in Prostate Cancer Cells, a Game-Changer for Treatment

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
TipRanks on MSN

Pfizer’s Prostate Cancer Study: Long-term Safety and Market Impact

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 2 Open-label Extension ...
Fierce Biotech

GSK pens $357M pact with French biotech for preclinical prostate cancer ADC

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

Surgeons at hospital do TWELVE prostate ops in a single day using high-tech robotic treatment as NHS waiting lists soar

Enlarged prostate is a common non-cancerous condition that affects older men but many patients wait months for care.

Prostate cancer survivor finds relief with new technology

Roberto Correa, a prostate cancer survivor, has found life-changing relief from incontinence thanks to new technology.